These stocks have an unusual volume in today's session Volume analysis on 2025-04-01: stocks with an unusual volume in today's session.
Monday's session: top gainers and losers Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Top movers analysis one hour before the close of the markets on 2025-03-28: top gainers and losers in today's session. Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Why Citius Pharmaceuticals (CTXR) Stock Is Down 15% Citius Pharmaceuticals shares are trading lower by 15% during Wednesday's session. The company announced a $3 million registered direct offering.
This Pharma Company Is Preparing To Launch Its Lead Candidate This Pharma Company Is Preparing To Launch Its Lead Candidate
CTXR Stock Earnings: Citius Pharma Meets EPS for Q3 2024 CTXR stock results show that Citius Pharma met analyst estimates for earnings per share the third quarter of 2024.
Penny Stock Citius Pharmaceuticals Secures Its First FDA Approval For Skin Cancer Drug A Year After FDA Rejection Citius Pharmaceuticals receives FDA approval for Lymphir, the first therapy targeting the IL-2 receptor in relapsed or refractory cutaneous T-cell lymphoma. U.S. market launch planned within five months.
Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology
Citius Pharmaceuticals Nears Market Breakthrough With Two Leading Products Citius Pharmaceuticals Nears Market Breakthrough With Two Leading Products
Citius Pharma's 'Antibiotic Lock' Effective In Patients With Catheter-Associated Bloodstream Infections Citius Pharmaceuticals' Phase 3 trial results for Mino-Lok, an antibiotic lock solution for central line-associated infections, show significant improvement in time to catheter failure and overall treatment success.
Yogi Tea Recalls: Yogi Brand Recalls 900,000 Tea Bags for Pesticide Residue Yogi Tea recalls are in effect for some of the company's tea bags over concerns of pesticide residue that may be found in them.
VFS Stock Alert: VinFast Plunges on NHTSA Probe VinFast Auto stock is down on Tuesday as investors in VFS learn that the company is being investigated over a fatal crash last month.
Why Is Citius Pharmaceuticals (CTXR) Stock Up 11% Today? Citius Pharmaceuticals stock is up on Tuesday with heavy trading of CTXR shares alongside positive clinical trial results.
CTXR Stock Earnings: Citius Pharma Meets EPS for Q2 2024 CTXR stock results show that Citius Pharma met analyst estimates for earnings per share the second quarter of 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning!
